Welcome back to Baby Breakerdom! This week's quest to uncover budding Rule Breakers finds a slim solution for a fat problem and a laser for your brain.
First up this week is NewHope Bariatrics, which aims to operate a series of surgery centers catering to the dangerously obese. I say "aims to" because, as of now, there are no clinics. That could change soon, though. On Tuesday, the company announced $18.5 million in first-round funding from a series of investors, including Austin Ventures, Versant Ventures, and Square 1 Bank.
Why so much interest? Part of the allure may be an expansion of Medicare coverage. According to a February report from the Centers for Medicare and Medicaid, the feds are expanding coverage of bariatric surgery to Medicare beneficiaries. Some coverage, however, appears to be conditional on the use of high-volume specialist centers of the sort NewHope's founders envision.
What's more, NewHope arrives at a time when medical specialists are making headway. Consider Psychiatric Solutions
Stock performance for these and other companies like them has been mixed, but there's clearly a trend at work here. And NewHope's founders have had experience taking advantage of the prevailing winds as senior executives at MedCath
Next up is Nanospectra Biosciences, which is working on a type of particle that, when combined with a laser, may be capable of safely destroying cancer cells. Talk about interesting technology!
Too bad it isn't further along. Last week, Nanospectra closed $1.7 million in early-stage funding, to bring its total financing to $3 million. That's a decent sum, but it's probably not close to what will be needed when (if?) the technology enters clinical trials. (Nanospectra says it will ask the FDA for permission to begin testing the technology on humans this year.)
Nevertheless, this is an area worth watching. Hospital networks such as Community Health Systems
That's all for now. See you back here next week, when we continue the quest to find the next Wal-Mart.
For more Rule Breaking Foolishness:
- Check in with last week's infants.
(NASDAQ:UARM)is a Rule Breakers pick. But is it good? Or bad?
- Get this week's 5 top growth stocks.
High-tech. Biotech. Nanotech. Any tech. David Gardner and his Foolish band of analysts cover it all for Motley Fool Rule Breakers selection, and they've unearthed four multibagger stocks in two years as a result. Want to find who they are?Try the servicefree for 30 days and find out.
Fool contributor Tim Beyers didn't own shares in any of the companies mentioned in this story at the time of publication. Get the skinny on all of the stocks he owns by checking Tim's Fool profile . The Motley Fool's disclosure policy is a rebel on Wall Street.